![Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction | Circulation: Cardiovascular Interventions Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/09e1fff8-0f01-4937-b4b3-fe366c175cd7/circinterventions.120.008969.fig03.jpg)
Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction | Circulation: Cardiovascular Interventions
![Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c02054/asset/images/medium/jm1c02054_0003.gif)
Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry
![Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | The BMJ Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | The BMJ](https://www.bmj.com/content/bmj/375/bmj.n2400/F2.medium.jpg)
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | The BMJ
![Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c02054/asset/images/large/jm1c02054_0002.jpeg)
Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry
![Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review | Stroke Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review | Stroke](https://www.ahajournals.org/cms/asset/a68c4a8f-0c4d-4a2b-b351-8ee16fa5e3a6/strokeaha.121.036824.fig04.jpg)
Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review | Stroke
![High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy - Journal of Allergy and Clinical Immunology High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/83c8c45e-b11e-4390-86c2-a2c33b3c1363/gr1_lrg.jpg)
High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy - Journal of Allergy and Clinical Immunology
![Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial - The Lancet Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/097f7d81-cb4f-4cd9-b8af-6b8adcedbbae/gr1.gif)
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial - The Lancet
![Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial - The Lancet Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d1e1757d-b689-44ca-b396-dc8db7a72222/gr2_lrg.jpg)
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial - The Lancet
Modification of Polyurethane Surface with an Antithrombin–Heparin Complex for Blood Contact: Influence of Molecular Weight of Polyethylene Oxide Used as a Linker/Spacer | Langmuir
![Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial - The Lancet Haematology Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2153530e-cdf3-4904-8b09-daaa24b31587/gr1.gif)
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial - The Lancet Haematology
![Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | The BMJ Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | The BMJ](https://www.bmj.com/content/bmj/375/bmj.n2400/F1.medium.jpg)
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | The BMJ
![Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c02054/asset/images/medium/jm1c02054_0006.gif)
Dynamic Combinatorial Optimization of In Vitro and In Vivo Heparin Antidotes | Journal of Medicinal Chemistry
![Risk of mortality drops in COVID-19 patients given anticoagulation within a day of hospital admission, research finds - The Pharmaceutical Journal Risk of mortality drops in COVID-19 patients given anticoagulation within a day of hospital admission, research finds - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/02/heparin-ss-20-scaled-e1613484643293.jpg)
Risk of mortality drops in COVID-19 patients given anticoagulation within a day of hospital admission, research finds - The Pharmaceutical Journal
![Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis - The Lancet Haematology Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5942b565-8f2a-47db-98da-51dfdfda3641/gr1.gif)
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis - The Lancet Haematology
![Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis | The BMJ Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis | The BMJ](https://www.bmj.com/content/bmj/344/bmj.e553/F4.large.jpg)
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis | The BMJ
![Swiss Medical Weekly - Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland Swiss Medical Weekly - Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland](https://smw.ch/rsrc/jf?tx_swajournal_file%5Baction%5D=index&tx_swajournal_file%5Bcontroller%5D=File&tx_swajournal_file%5Bidentifier%5D=smw.2020.20210&tx_swajournal_file%5Bjournal%5D=ezm_smw&tx_swajournal_file%5Blanguage%5D=en&tx_swajournal_file%5Bmode%5D=view&tx_swajournal_file%5Bresource%5D=http%3A%2F%2Fprodclient.emh02.snowflakehosting.ch%2Fapi%2Ffile%2Fproduction%2Fb5%2Fb5580cfdda8dccc6dc0d597905abd7c021b630e8%2F20210_head.jpg&tx_swajournal_file%5Btype%5D=article)
Swiss Medical Weekly - Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
![Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease - Kidney International Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7723c62c-5aca-4e35-a381-f67c566f7b65/fx1_lrg.jpg)
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease - Kidney International
![Selectively Desulfated Heparin Inhibits Fibroblast Growth Factor-induced Mitogenicity and Angiogenesis* - Journal of Biological Chemistry Selectively Desulfated Heparin Inhibits Fibroblast Growth Factor-induced Mitogenicity and Angiogenesis* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/475e78a4-bc43-47ed-8415-b119ed6de262/gr1_lrg.jpg)